Park Ha CTO reports initial share holdings

Park Ha Biological Technology Co., Ltd. CTO Li Xinyu has reported initial ownership on a Form 3.

Accepted by SEC EDGAR 04/07/2026 - 08:27 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. CTO Li Xinyu has reported initial ownership on a Form 3. The filing shows 937.5 Class A Ordinary Shares are held indirectly through Changxin International Limited Partnership, where Ms. Li is a limited partner. A footnote states these shares were acquired on October 11, 2022.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Li Xinyu

Role CTO

Type	Security	Shares	Price	Value
Holding	Class A Ordinary Shares	--	--	--

Holdings: Class A Ordinary Shares — 937.5 shares (Indirect, By Changxin International Limited Partnership)

Footnotes (1)

1. F1. Directly held by Changxin Internatonal Limited Partnership. Ms. Li is the limited partner of Changxin Internatonal Limited Partnership. The Reporting Person acquired 937.5 Class A Ordinary Shares on October 11, 2022.

Key Figures

Indirectly held shares: 937.5 shares Acquisition date of reported shares: October 11, 2022 Ownership type: Indirect (I) +1 more

4 metrics

Indirectly held shares 937.5 shares Class A Ordinary Shares held via Changxin International Limited Partnership

Acquisition date of reported shares October 11, 2022 Footnote states acquisition date for 937.5 Class A Ordinary Shares

Ownership type Indirect (I) Reported as held by Changxin International Limited Partnership

Reporting person role CTO Li Xinyu serves as Chief Technology Officer of the issuer

Key Terms

Class A Ordinary Shares, indirect ownership, Limited Partnership, Form 3

4 terms

Class A Ordinary Shares financial

"The Reporting Person acquired 937.5 Class A Ordinary Shares on October 11, 2022."

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

indirect ownership financial

"total_shares_following_transaction ... direct_or_indirect: "I", ownership_type: "indirect""

Limited Partnership financial

"Directly held by Changxin Internatonal Limited Partnership. Ms. Li is the limited partner"

A limited partnership is a legal business structure with two types of partners: at least one general partner who runs the business and bears full legal responsibility, and one or more limited partners who contribute money, share profits, and have liability capped at their investment. For investors, it matters because it separates control from financial exposure — like putting money into a store without managing it — and affects how returns, risks, taxes and transferability of ownership are handled.

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Park Ha Biological Technology (BYAH) Form 3 for Li Xinyu show?

The Form 3 shows CTO Li Xinyu has an indirect position of 937.5 Class A Ordinary Shares in Park Ha Biological Technology. These shares are held through Changxin International Limited Partnership and were originally acquired on October 11, 2022, according to the footnote.

How many Park Ha Biological Technology (BYAH) shares does the CTO report?

The CTO reports 937.5 Class A Ordinary Shares following the reported position. The filing characterizes this as indirect ownership through Changxin International Limited Partnership, rather than shares held directly in Ms. Li’s own name, based on the ownership description provided.

Is Li Xinyu’s ownership in BYAH direct or indirect on this Form 3?

The ownership is reported as indirect. The Form 3 indicates the 937.5 Class A Ordinary Shares are held by Changxin International Limited Partnership, with a notation that Ms. Li is a limited partner of that partnership, rather than directly holding the shares herself.

Does the BYAH Form 3 for Li Xinyu report a new share transaction?

The Form 3 primarily records existing holdings instead of a new trade. A footnote states the 937.5 Class A Ordinary Shares were acquired on October 11, 2022, meaning the filing documents prior ownership rather than an immediate buy or sell event.

Who actually holds the BYAH shares reported for Li Xinyu?

The shares are held by Changxin International Limited Partnership. The Form 3 notes that Ms. Li is a limited partner of this partnership, and the 937.5 Class A Ordinary Shares are attributed to her as indirect ownership through that entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Xinyu

(Last) (First) (Middle)

ROOM 202, NO. 31, LANE 1152

HUAXIA EAST ROAD, PUDONG NEW DISTRICT

(Street)

SHANGHAI 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2024

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CTO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	937.5	I	By Changxin International Limited Partnership(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Directly held by Changxin Internatonal Limited Partnership. Ms. Li is the limited partner of Changxin Internatonal Limited Partnership. The Reporting Person acquired 937.5 Class A Ordinary Shares on October 11, 2022.

	/s/ Li Xinyu	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)